PharmStars Fall 2026 Accelerator: Digital Innovations in Immunology — Frequently Asked Questions
Answers to the questions founders most often ask about PharmStars Fall 2026 Accelerator: Digital Innovations in Immunology — who qualifies, the funding amount, required documents and how the application works.
Frequently asked questions
How much funding does the PharmStars Fall 2026 Accelerator provide?
The accelerator offers an investment from the PharmStars Ventures Fund to selected startups. The exact amount is not specified and varies per startup.
What is the application deadline?
Applications opened on June 1, 2026, and must be submitted online by July 12, 2026.
Who is eligible to apply?
Digital health startups worldwide with market-ready products or prototypes focusing on immunology innovations are eligible. There are no geographic restrictions or requirements for DPIIT or MSME registration.
Does the accelerator take equity?
Yes, this is an equity-based funding program. The PharmStars Ventures Fund invests in exchange for an equity stake in the startup.
What is the program structure?
The program is a 10-week virtual accelerator that includes the PharmaU curriculum, personalized mentoring, direct pharma access, and a Startup Showcase. It runs virtually with a launch event on September 9-10, 2026.
What types of digital health solutions are you looking for?
The cohort theme is "Digital Innovations in Immunology." We seek solutions addressing immune system conditions such as autoimmune diseases, inflammatory conditions, allergies, and asthma. This includes improving patient identification, diagnosis, personalized treatment, disease monitoring, drug development, safety, and patient access.
Can early-stage startups apply?
The program requires market-ready solutions with a product or prototype. While early-stage startups with a prototype are eligible, the program is best suited for startups that have advanced beyond the ideation stage.
How are startups selected?
Applications are reviewed by a committee of former pharma executives and pharma member representatives. They evaluate alignment with the immunology theme, market readiness, and partnership potential. Shortlisted startups may be interviewed. Final decisions are communicated by August 26, 2026.
What documents are needed to apply?
Applicants must submit all required documents as specified in the Accelerator Terms. These typically include a completed application form, pitch deck, and possibly other supporting materials. Details are provided on the official application portal.
How do I apply?
Applications are submitted online through the official PharmStars application portal at https://www.pharmstars.com/applyarch.
Is DPIIT recognition required for PharmStars Fall 2026 Accelerator: Digital Innovations in Immunology?
No. DPIIT (Startup India) recognition is not listed as a mandatory requirement for PharmStars Fall 2026 Accelerator: Digital Innovations in Immunology, though having it can strengthen your application and unlock other benefits.
Who offers PharmStars Fall 2026 Accelerator: Digital Innovations in Immunology?
PharmStars Fall 2026 Accelerator: Digital Innovations in Immunology is offered by PharmStars, a startup accelerator. It is provided as an investment.
← Back to PharmStars Fall 2026 Accelerator: Digital Innovations in Immunology overview